| ELUT | This page provides the latest news and market updates for Elutia Inc. (ELUT), a regenerative medicine company focusing on drug-eluting biomatrix products. It covers recent developments such as compliance with Nasdaq listing requirements, executive appointments, financial results, and progress on their NXT-41 and NXT-41x biomatrix programs for reconstructive surgery. The company aims to leverage asset sale proceeds to fund the development and commercialization of these products. | Bullish | 2026-03-09 22:23:02 |
| FLNT | Fluent Inc. announced its performance outlook, predicting double-digit percentage growth in total revenue from continuing operations for fiscal year 2026. The company also anticipates an improving trend in its adjusted EBITDA. This positive forecast is attributed to confidence in core business growth and strategic efforts to boost profitability through operational efficiency. | Bullish | 2026-03-09 22:23:02 |
| FMFC | Kandal M Venture has acquired a 15% stake in Dumaine International for $2.5 million, marking its first overseas manufacturing base in the Philippines. This strategic move aims to diversify Kandal's manufacturing footprint beyond Cambodia, reducing geographic risk and enhancing its capacity to attract more global contract clients in the affordable luxury segment. The investment provides access to a large facility and over 3,500 workers, supporting Kandal's growth and regional competitiveness. | Bearish | 2026-03-09 22:23:02 |
| ADP | This article provides 11 strategies for retaining top talent in 2026, emphasizing the importance of an attractive company culture, effective leadership, and competitive compensation. It also highlights offering challenging work, flexibility, recognition, and continuous training while using data-driven decisions to understand employee needs. The core message is that investing in current employees fosters a positive environment and benefits the company's bottom line. | Bullish | 2026-03-09 22:23:02 |
| MGM | MGM Resorts International will participate in the J.P. Morgan Gaming Lodging Restaurant and Leisure Management Access Forum on March 12, 2026, to showcase its developments in leisure, gaming, and hospitality. The company aims to expand its global footprint, including new international ventures and its partnership with BetMGM, to provide innovative and immersive luxury travel experiences. MGM Resorts will also share insights on emerging trends, sustainability, and eco-tourism in the luxury travel sector, particularly concerning its expansion into Asia. | Bullish | 2026-03-09 22:23:02 |
| HUM | Humana (HUM) has issued $1 billion in 6.625% fixed-to-fixed rate junior subordinated notes due 2056 to enhance liquidity and potentially repay existing debt. The notes are deeply subordinated and feature a coupon reset every five years after 2031, with optional interest deferrals for up to 10 consecutive years. TipRanks' AI Analyst, Spark, rates HUM as "Neutral," citing weaker 2025 cash-flow conversion and margin compression, despite long-term recovery prospects from membership growth and efficiency initiatives. | Bearish | 2026-03-09 22:23:02 |
| ABT | Abbott Laboratories (ABT) has completed a $20 billion multi-tranche senior notes offering, with maturities ranging from 2029 to 2066. The proceeds are primarily intended to fund the acquisition of Exact Sciences Corporation, refinance existing Exact Sciences debt, and cover transaction costs, with a protective redemption feature for bond investors if the deal falls through. TipRanks' AI Analyst, Spark, rates ABT as Neutral due to strong financial performance offset by valuation concerns and market volatility. | Bearish | 2026-03-09 22:23:02 |
| D | Hampton Roads Dominion Energy customers are expressing widespread frustration and confusion over unexpectedly high utility bills, with many reporting their recent bills are double what they were last year. People like Erica Hardy are facing power shut-offs and financial distress, while Faith Booker received a first bill of over $600 for less than a month of service. The situation has prompted hundreds of social media comments and a planned protest at Dominion's office in Norfolk, highlighting a significant issue for residents living paycheck to paycheck. | Bearish | 2026-03-09 22:23:02 |
| HII | Chad Boudreaux, VP of Huntington Ingalls Industries (NYSE:HII), sold 4,400 shares of the company's stock on March 5th for a total of $1,858,780. This transaction reduced his direct ownership by 17.77%. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend. | Bearish | 2026-03-09 22:23:02 |
| MGM | MGM Resorts International Director Keith Meister sold 37,500 shares of company stock for a total of $1,285,125.00, reducing his direct ownership by 0.70%. The sale occurred on March 9th at an average price of $34.27 per share. Following the transaction, Meister directly owns 5,347,978 shares valued at over $183 million. | Bearish | 2026-03-09 22:23:02 |
| MO | Altria Group (NYSE:MO) SVP Charles Whitaker sold 27,908 shares of the company's stock on March 5th for a total of $1,885,743.56. This sale reduced his direct ownership by 13.37% to 180,869 shares. The article also provides details on the company's stock performance, recent dividend declaration, institutional investor activity, and analyst ratings. | Bearish | 2026-03-09 22:23:02 |
| EXLS | EXL Australia and New Zealand announced its "AI in Action 2026" virtual event, scheduled for March 24, 2026, aimed at helping enterprises move beyond AI experimentation to achieve measurable business value. The event will feature senior leaders from global technology, financial services, and AI innovation, including Rohit Kapoor (EXL CEO) and Jon McNeill (former Tesla President), to discuss practical roadmaps for embedding AI into core operations and realizing its true value. It will address common barriers to AI scaling, such as workflow integration, data environments, and translating insights into action, through sessions on AI-enabled workflows, data modernization, and agentic AI. | Bullish | 2026-03-09 22:23:02 |
| HUM | Humana Inc. announced the completion of its public offering of $1.0 billion in fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount. The net proceeds of approximately $986 million from this offering will be used for general corporate purposes, including the potential repayment of existing indebtedness. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc., and Wells Fargo Securities, LLC acted as lead managers for the offering. | Bullish | 2026-03-09 22:23:02 |
| VLO | Valero Energy has entered into an underwriting agreement to issue $850 million of 5.150% Senior Notes due 2036. This move aims to raise long-term capital for general corporate purposes, with the closing of the notes expected on March 10, 2026. The notes will be offered under Valero’s existing indenture and pursuant to an effective shelf registration. | Bullish | 2026-03-09 22:23:02 |
| MDT | MiniMed (Nasdaq:MMED) announced the completion of its $560 million IPO, with shares trading at $18 after pricing at $20. The company retained $309 million of the net proceeds and currently has $350 million in cash, which it plans to use for general corporate purposes and to repay debt to Medtronic. Medtronic now owns approximately 90.03% of MiniMed, as the separation process continues, involving board changes and ongoing product development efforts. | Bullish | 2026-03-09 22:23:02 |
| EXPI | This article recommends selling EXPI (eXp World Holdings Inc) due to disappointing long-term revenue growth, mediocre free cash flow margins, and declining return on invested capital. The stock has dropped 41.3% in the past six months and is considered overvalued at 26.1x forward P/E, despite the lower share price. Instead of EXPI, the author suggests considering a dominant software business and highlights high-momentum stocks identified by StockStory's AI platform, citing Nvidia and Kadant as examples of past successes. | Bearish | 2026-03-09 22:23:02 |
| FLNT | Fluent Inc. reported its financial results for Q4 and the full fiscal year 2025. The data and analytics firm experienced a net loss of $4.1 million in Q4, or thirteen cents per share, with adjusted losses at nine cents per share and quarterly revenue hitting $61.8 million. For the entire fiscal year, Fluent Inc. recorded an annual loss of $27.2 million ($1.05 per share) on total annual revenue of $208.8 million. | Bearish | 2026-03-09 22:23:02 |
| HUM | Humana Inc. successfully completed a public offering of $1 billion in fixed-to-fixed rate junior subordinated notes due 2056 with an interest rate of 6.625 percent. The health insurer expects net proceeds of approximately $986 million, which it plans to use for general corporate purposes, including repaying existing debt. Goldman Sachs, J.P. Morgan Securities, Mizuho Securities, Truist Securities, and Wells Fargo Securities served as joint book-running managers for the offering. | Bullish | 2026-03-09 22:23:02 |
| EYE | Fahs L Reade, Executive Chairman of National Vision Holdings (NASDAQ:EYE), sold 11,672 shares of common stock for $345,217 on March 6, 2026, executed under a Rule 10b5-1 trading plan. The sale occurred near the stock's 52-week high after a 129% gain over the past year. Analysts maintain a bullish outlook on the company, which has surpassed earnings and revenue expectations and shown consistent comparable store sales growth. | Bullish | 2026-03-09 22:23:02 |
| VMC | Vulcan Materials (NYSE:VMC) operates within the crucial construction aggregates sector, supplying essential materials for infrastructure and urban development. Demand for aggregates is closely tied to infrastructure construction and highway development. Recent discussions and sentiment around the company have focused on its shipment activity. | Bearish | 2026-03-09 22:23:02 |
| WST | West Pharmaceutical Services (NYSE:WST) announced that CEO Eric Green plans to retire in the second half of 2026, after a successor is appointed. Green has led the company for 11 years, during which sales more than doubled and shareholder return reached approximately 350%, aligning with strong InvestingPro data. The company, a provider of injectable solutions, also reaffirmed its guidance and recently reported strong Q4 2025 earnings and a new $1 billion share repurchase program. | Bullish | 2026-03-09 22:23:02 |
| TMO | Thermo Fisher Scientific has opened its first U.S. cryo-electron microscopy (cryo-EM) center in South San Francisco, featuring a 10-foot-tall microscope. The company aims to accelerate drug discovery by making this advanced technology accessible to biotech and pharmaceutical clients. This initiative marks a significant step for Thermo Fisher in the Bay Area's biotech landscape. | Bullish | 2026-03-09 22:23:02 |
| D | Dominion Energy's recent monthly rate increase has significantly impacted residents in Hampton Roads, with many reporting their bills have doubled or tripled despite efforts to conserve energy. The utility company states the increase is due to inflationary pressures, and while the approved hike was $11.24, customers feel the actual impact is much higher. Dominion Energy offers assistance programs, including budget billing and EnergyShare, to help customers manage their energy costs. | Bearish | 2026-03-09 22:23:02 |
| GS | This SEC Form 424B2 filing from GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., details Callable Contingent Coupon Underlier-Linked Notes due March 19, 2029. The notes' performance is linked to the S&P 500® Index, Russell 2000® Index, and VanEck Semiconductor ETF, offering potential monthly coupons if underliers meet certain levels, but risking principal loss if they fall below buffer levels. The document also provides extensive risk factors, hypothetical payment scenarios, and U.S. federal income tax consequences for investors. | Bearish | 2026-03-09 22:23:02 |
| JPM | JPMorgan Chase Financial Company LLC has issued $1,395,000 Knock-Out Notes linked to the SPDR® Gold Trust, with JPMorgan Chase & Co. fully and unconditionally guaranteeing these notes. These structured investments mature on March 9, 2028, and are designed for investors seeking returns based on the appreciation of the SPDR® Gold Trust, with specific conditions for fixed or variable payouts and a limited downside risk. The filing includes details on risk considerations, hypothetical payout profiles, and tax treatment for investors. | Bearish | 2026-03-09 22:23:02 |
| PYPL | PayPal (NASDAQ:PYPL) saw its stock price drop 1.7% on Monday, trading at $46.16 with lower-than-average volume. This comes after the company missed Q4 earnings and revenue estimates, leading to analysts maintaining a "Hold" consensus with some downgrades and reduced price targets. Insiders have also sold a significant number of shares recently, contributing to investor uncertainty. | Bearish | 2026-03-09 22:23:02 |
| SMCI | Super Micro Computer (SMCI) saw its stock rise by 2.1% during mid-day trading following a strong Q4 earnings beat, where the company exceeded EPS and revenue expectations, and reported a 123.4% year-over-year revenue increase. Despite the positive earnings, several analysts have recently cut price targets, resulting in a consensus "Hold" rating for the stock. Institutional ownership of SMCI stands at approximately 84.06%, with various firms adjusting their stakes in the company during the fourth quarter. | Bullish | 2026-03-09 22:23:02 |
| VZ | Verizon Communications (NYSE:VZ) shares dropped 1.4% to $50.4060 on Monday, March 9, 2026, though the stock has a "Moderate Buy" consensus rating from analysts with an average target price of $49.28. The company recently reported better-than-expected quarterly earnings of $1.09 EPS and $36.38 billion in revenue, and increased its quarterly dividend to $0.7075, offering a 5.6% yield. Institutional investors have significantly increased their holdings in Verizon, while some insiders have sold shares. | Bearish | 2026-03-09 22:23:02 |
| VRTX | Vertex Pharmaceuticals Inc. saw its shares rise by as much as 11% following the successful late-stage trial of its new kidney disorder drug, povetacicept. The drug achieved a significant reduction in protein in patients' urine, marking a key step in the company's strategy to expand beyond cystic fibrosis treatments. The trial results indicated the drug was safe and well-tolerated. | Bullish | 2026-03-09 22:23:02 |
| INTC | Intel's stock has more than doubled in value over the past year, reaching a 52-week high in January before dropping 18%. While the company's foundry business shows growth, the overall revenue is down, and the foundry segment incurred a significant operating loss. The stock is currently considered expensive, trading at 85 times its expected future earnings, leading the author to believe it may have peaked. | Bearish | 2026-03-09 22:23:02 |
| VLO | Valero Energy (VLO) stock dropped 3.7% due to a crude-price shock from Middle East conflict headlines, raising concerns about inflation and demand destruction, which can severely impact refiners' profitability by narrowing crack spreads. Additionally, uncertainty surrounding the timing of maintenance activities at Valero's St. Charles refinery contributed to investor apprehension. Despite a recent rally based on improving refining conditions, the current market volatility led to profit-taking. | Bearish | 2026-03-09 22:23:02 |
| JBHT | J.B. Hunt Transport Services Inc. has announced its common stock will be dual-listed on Nasdaq Texas LLC, a new venue expanding Nasdaq's presence in Texas. The Lowell-based company will maintain its listing on the Nasdaq global market under the symbol JBHT. This move is expected to support J.B. Hunt's investment in its operations within Texas, where it serves over 1,800 customers and employs around 3,100 people. | Bullish | 2026-03-09 22:23:02 |
| HON | Honeywell CEO Vimal Kapur received a $20.4 million total compensation package in 2025 amidst the company's aerospace spinoff. Jim Currier, who is set to lead the new Phoenix-based aerospace company, has a base salary slightly below Kapur's $1.6 million. This information was revealed in recent SEC filings. | Bearish | 2026-03-09 22:23:02 |
| ABBV | AbbVie CEO Robert Michael's total compensation for 2025 was $32.5 million, as disclosed in an SEC filing. The article, published by Reuters via MarketScreener, reports this financial detail for the pharmaceutical company's executive. | Bearish | 2026-03-09 22:23:02 |
| ARE | Alexandria Real Estate Equities (ARE) has declared a steady quarterly cash dividend of US$0.72 per share, indicating a focus on balance sheet reinforcement and liquidity, despite broader pressures in the biotech sector. This dividend decision, along with a significant Q4 2025 impairment and tender offers for long-dated notes, suggests a capital structure reset. Investors are awaiting Q1 2026 results and further clarity on occupancy and rent trends to fully assess the company's investment narrative. | Bearish | 2026-03-09 22:23:02 |
| MNST | Monster Beverage (MNST) has experienced significant growth, outperforming the S&P 500, leading investors to question if it's still a good buy. The company demonstrates strong financial health through high operating margins, excellent free cash flow margins, and stellar return on invested capital (ROIC), making it a top contender in the consumer staples sector. These factors highlight Monster's profitability, reinvestment potential, and efficient growth strategies. | Bullish | 2026-03-09 22:23:02 |
| C | Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is offering Autocallable Contingent Coupon Equity Linked Securities linked to the Nasdaq-100, Russell 2000, and S&P 500 Indexes. These unsecured debt securities offer potential for higher periodic contingent coupon payments (approx. 11.65% per annum) but carry significant risks, including potential loss of principal, no participation in underlying appreciation, and early automatic redemption. The securities are not bank deposits and will not be listed on any exchange. | Bullish | 2026-03-09 22:23:02 |
| KO | Diet Cherry Coke, a classic flavor first introduced in 1985, is making a comeback in Washington stores after becoming hard to find. Shoppers have reported seeing it at major retailers like Walmart, and it is expected to appear in other large grocery chains. This resurgence follows national sightings in retro-style cans and meets a renewed demand for classic soda flavors. | Bullish | 2026-03-09 22:23:02 |
| VRTX | Vertex Pharmaceuticals announced that its experimental kidney disease drug, povetacicept, successfully met the main goal in a late-stage trial for IgA nephropathy. The drug led to a 52% reduction in protein leakage in urine for patients after 36 weeks, significantly outperforming the placebo group's 4.3% drop. Following the positive results, Vertex's shares rose approximately 10% in extended trading. | Bullish | 2026-03-09 22:23:02 |
| WST | West Pharmaceutical Services (WST) announced that CEO Eric Green plans to retire in late 2026, following the appointment of a successor. The company is actively searching for a replacement while maintaining its previously issued financial guidance to ensure stability. West Pharmaceutical Services is a healthcare supplier specializing in packaging and delivery systems for injectable drugs, with strong financial health and positive analyst sentiment despite some long-term declines in gross and operating margins. | Bearish | 2026-03-09 22:23:02 |
| GD | General Dynamics (GD) has announced a 6% increase in its quarterly dividend, raising it to $1.59 per share, resulting in a forward yield of 1.77%. The company, a prominent defense contractor and business jet manufacturer, shows strong financial health with consistent revenue growth and a stable balance sheet. While valuation metrics are near historical highs and insider selling has occurred, analyst sentiment remains cautiously optimistic. | Bullish | 2026-03-09 22:23:02 |
| A | Agilent Technologies announced its all-cash acquisition of privately held clinical pathology firm Biocare Medical for $950 million. This strategic move aims to expand Agilent's presence in clinical diagnostics and life sciences by integrating Biocare Medical's specialized tissue diagnostic capabilities. The deal is expected to close by the fourth fiscal quarter of 2026, positioning Agilent to offer more comprehensive solutions to laboratories and advance precision medicine. | Bullish | 2026-03-09 22:23:02 |
| STT | State Street Corporation and its subsidiaries have announced they are no longer a substantial holder in Service Stream Limited (AU:SSM) as of March 5, 2026. This change occurred because their aggregated relevant interest in Service Stream's voting securities fell below the substantial holding threshold, which may affect the company's institutional ownership and market liquidity. Service Stream currently has an analyst rating of "Hold" with a price target of A$2.00. | Bearish | 2026-03-09 22:23:02 |
| STT | State Street Corporation and its subsidiaries have announced they are no longer substantial holders in Liontown Resources Limited, indicating their aggregate voting power has fallen below the disclosure threshold. This change in institutional ownership may affect Liontown's ownership profile and governance dynamics. Liontown Resources Limited is an Australian-listed company in the resources sector, with a current market cap of A$4.96 billion. | Bearish | 2026-03-09 22:23:02 |
| NEM | Newmont Corporation (NEM) is attracting significant analyst attention, with BofA and Bernstein SocGen Group recently raising price targets and upgrading the stock to Buy and Outperform, respectively. Analysts cite a bullish outlook on gold, a new CEO with a solid plan, and revised metal price estimates for 2026 as key drivers. The majority of analysts recommend buying NEM, with a median price target suggesting a substantial upside potential. | Bullish | 2026-03-09 22:23:02 |
| VRTX | Vertex announced that its drug, acquired through a $4.9 billion acquisition, successfully reduced a key marker of IgA nephropathy by half in a Phase 3 trial. This outcome matches data from Otsuka's recently approved Voyxact and is numerically superior to results from Vera Therapeutics. The treatment targets a disease affecting 330,000 people in the U.S. and Europe, with analysts projecting over $4 billion in annual sales for Vertex's drug. | Bullish | 2026-03-09 22:23:02 |
| MGM | MGM Resorts International announced its participation in the J.P. Morgan Gaming, Lodging, Restaurant and Leisure Management Access Forum on March 12, 2026. The company's management will speak at a session at 2:00 p.m. ET, which will be webcast live on its investor relations website. This engagement offers insights into MGM Resorts' strategic priorities and outlook within the gaming, hospitality, and leisure sectors. | Bullish | 2026-03-09 22:23:02 |
| HPE | Hewlett Packard Enterprise (HPE) projects second-quarter revenue to exceed Wall Street estimates due to strong demand for its AI-powered servers, forecasting between $9.6 billion and $10.0 billion. The company also raised its fiscal 2026 adjusted earnings per share forecast and noted its AI backlog surpassed $5 billion in the first quarter. This optimism reflects the booming investment in AI infrastructure by major tech firms, despite HPE's stock underperforming rivals like Dell. | Bullish | 2026-03-09 22:23:02 |
| ETH | This article discusses the scarcity of Bitcoin, noting that the 20 millionth Bitcoin was mined today, leaving approximately 1 million left. It explains how Bitcoin's supply is programmatically capped at nearly 21 million through halving events, ensuring its inherent scarcity despite short-term volatility. The author argues that this predictable and transparent supply mechanism drives Bitcoin's value as a store of value. | Bullish | 2026-03-09 22:23:02 |
| FIHL | UBS Group has raised its price target for Fidelis Insurance (NYSE:FIHL) to $25.00 from $24.00, maintaining a "buy" rating and implying a potential 33.44% upside. This follows Fidelis Insurance beating Q4 EPS estimates but missing revenue expectations, along with authorizing a $400 million share buyback program. Despite mixed analyst ratings, the consensus price target for FIHL is $22.36, with the stock currently trading around $18.74. | Bullish | 2026-03-09 22:23:02 |